LE WE PMID CA
Axitinib4397Axitinib

Axitinib

Motesanib

Pazopanib

Sorafenib

Thyroid (Neoplasia)

Tivozanib ttVEGF

Vadetanib

VEGF

XL184

2010  
1
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer.
[20694064] Core Evid 4(-): 43-8 (2010)
2009  
2
Axitinib--a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor.
[19876699] Target Oncol 4(4): 297-305 (2009)
2011  
3
Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.
[21383525] Endocr J 58(3): 151-3 (2011)
2011  
4
Development of second-generation VEGFR tyrosine kinase inhibitors: current status.
[21318618] Curr Oncol Rep 13(2): 103-11 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Axitinib

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia